DXCM Q4 2020 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$569M+22.9% YoY

Gross Profit

$399M70.2% margin

Operating Income

$104M18.3% margin

Net Income

$355M62.4% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

+13.6%

Cash Flow

Operating Cash Flow

$172M

Free Cash Flow

$112M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$4.3B

Total Liabilities

$2.5B

Stockholders' Equity

$1.8B

Cash & Equivalents

$818M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$569M	$463M	+22.9%
Gross Profit	$399M	$309M	+29.0%
Operating Income	$104M	$102M	+2.5%
Net Income	$355M	$93M	+283.2%

Geographic Segments

UNITED STATES

$452M79%

Non-US

$117M21%